| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cell Transformation, Neoplastic | 5 | 2011 | 204 | 0.670 |
Why?
|
| Mitogen-Activated Protein Kinases | 7 | 2004 | 213 | 0.550 |
Why?
|
| Diet, High-Fat | 5 | 2025 | 180 | 0.460 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 9 | 2018 | 140 | 0.430 |
Why?
|
| Adaptor Proteins, Signal Transducing | 3 | 2018 | 439 | 0.390 |
Why?
|
| ras Proteins | 2 | 2003 | 76 | 0.380 |
Why?
|
| Obesity | 5 | 2025 | 1264 | 0.380 |
Why?
|
| Signal Transduction | 12 | 2025 | 3154 | 0.360 |
Why?
|
| Hepatocytes | 4 | 2022 | 222 | 0.340 |
Why?
|
| Liver | 4 | 2022 | 868 | 0.330 |
Why?
|
| PPAR alpha | 2 | 2022 | 33 | 0.310 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 2 | 2018 | 90 | 0.280 |
Why?
|
| N-Methylaspartate | 1 | 2007 | 16 | 0.270 |
Why?
|
| Mice | 24 | 2025 | 11120 | 0.260 |
Why?
|
| Mitogen-Activated Protein Kinase 14 | 1 | 2007 | 10 | 0.260 |
Why?
|
| Insulin Resistance | 4 | 2017 | 414 | 0.260 |
Why?
|
| Apoptosis | 6 | 2019 | 1095 | 0.250 |
Why?
|
| Mice, Knockout | 13 | 2022 | 2154 | 0.230 |
Why?
|
| Animals | 26 | 2025 | 21347 | 0.220 |
Why?
|
| Phosphorylation | 8 | 2025 | 962 | 0.220 |
Why?
|
| Oxidative Stress | 1 | 2007 | 319 | 0.220 |
Why?
|
| Neoplasms | 2 | 2007 | 1362 | 0.220 |
Why?
|
| Gene Expression Profiling | 5 | 2017 | 793 | 0.210 |
Why?
|
| Adipose Tissue | 3 | 2017 | 299 | 0.200 |
Why?
|
| Gene Expression Regulation | 5 | 2020 | 1634 | 0.200 |
Why?
|
| Mice, Inbred C57BL | 9 | 2025 | 3478 | 0.200 |
Why?
|
| Eukaryotic Cells | 1 | 2003 | 57 | 0.190 |
Why?
|
| Inflammation | 3 | 2020 | 1191 | 0.180 |
Why?
|
| Mitogen-Activated Protein Kinase 8 | 4 | 2011 | 86 | 0.180 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2003 | 210 | 0.180 |
Why?
|
| Metabolic Syndrome | 1 | 2022 | 146 | 0.170 |
Why?
|
| CLOCK Proteins | 1 | 2020 | 47 | 0.170 |
Why?
|
| Phosphotyrosine | 1 | 2019 | 25 | 0.150 |
Why?
|
| Bcl-2-Like Protein 11 | 1 | 2019 | 20 | 0.150 |
Why?
|
| Neurons | 3 | 2018 | 941 | 0.140 |
Why?
|
| fas Receptor | 1 | 2019 | 56 | 0.140 |
Why?
|
| Spatial Memory | 1 | 2018 | 8 | 0.140 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2019 | 673 | 0.140 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2019 | 269 | 0.130 |
Why?
|
| Metabolome | 1 | 2017 | 36 | 0.130 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2013 | 607 | 0.130 |
Why?
|
| Neutrophils | 1 | 2020 | 396 | 0.130 |
Why?
|
| Caloric Restriction | 1 | 2017 | 21 | 0.130 |
Why?
|
| Mitogen-Activated Protein Kinase Phosphatases | 2 | 2015 | 6 | 0.130 |
Why?
|
| Immunologic Memory | 1 | 2019 | 281 | 0.120 |
Why?
|
| Epigenomics | 1 | 2017 | 62 | 0.120 |
Why?
|
| Neuronal Plasticity | 1 | 2018 | 153 | 0.120 |
Why?
|
| Mitogen-Activated Protein Kinase 10 | 1 | 2016 | 12 | 0.120 |
Why?
|
| Stress, Physiological | 2 | 2016 | 209 | 0.120 |
Why?
|
| Fibroblasts | 4 | 2011 | 415 | 0.120 |
Why?
|
| Somatostatin-Secreting Cells | 1 | 2015 | 8 | 0.110 |
Why?
|
| Glucagon-Secreting Cells | 1 | 2015 | 26 | 0.110 |
Why?
|
| Fetus | 1 | 2015 | 101 | 0.110 |
Why?
|
| Transcriptome | 1 | 2017 | 396 | 0.100 |
Why?
|
| Insulin-Secreting Cells | 1 | 2015 | 194 | 0.100 |
Why?
|
| Islets of Langerhans | 1 | 2015 | 286 | 0.100 |
Why?
|
| Cells, Cultured | 6 | 2020 | 2190 | 0.090 |
Why?
|
| Reactive Oxygen Species | 2 | 2019 | 241 | 0.090 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2019 | 731 | 0.090 |
Why?
|
| MAP Kinase Kinase 4 | 2 | 2022 | 46 | 0.090 |
Why?
|
| RNA | 1 | 2015 | 426 | 0.090 |
Why?
|
| Fibroblast Growth Factors | 2 | 2022 | 77 | 0.090 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2015 | 662 | 0.090 |
Why?
|
| Sirtuin 1 | 1 | 2011 | 27 | 0.080 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2011 | 62 | 0.080 |
Why?
|
| Precancerous Conditions | 1 | 2011 | 74 | 0.080 |
Why?
|
| Fatty Liver | 1 | 2011 | 111 | 0.080 |
Why?
|
| Enzyme Activation | 5 | 2011 | 392 | 0.080 |
Why?
|
| Male | 10 | 2025 | 30904 | 0.070 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2009 | 61 | 0.070 |
Why?
|
| Protein Tyrosine Phosphatases | 2 | 2007 | 59 | 0.070 |
Why?
|
| COS Cells | 1 | 2007 | 180 | 0.070 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2007 | 78 | 0.060 |
Why?
|
| Cerebellum | 1 | 2007 | 94 | 0.060 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2007 | 131 | 0.060 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2007 | 88 | 0.060 |
Why?
|
| Mice, Transgenic | 2 | 2020 | 1290 | 0.060 |
Why?
|
| Transcription Factor AP-1 | 2 | 2003 | 46 | 0.060 |
Why?
|
| Lung Neoplasms | 2 | 2011 | 702 | 0.060 |
Why?
|
| Mice, Nude | 2 | 2004 | 287 | 0.060 |
Why?
|
| Cellular Senescence | 1 | 2006 | 120 | 0.060 |
Why?
|
| Isocitrate Dehydrogenase | 1 | 2025 | 28 | 0.060 |
Why?
|
| Dietary Fats | 3 | 2011 | 178 | 0.060 |
Why?
|
| Sequence Analysis, RNA | 2 | 2017 | 180 | 0.050 |
Why?
|
| Autocrine Communication | 1 | 2004 | 30 | 0.050 |
Why?
|
| Muscle, Skeletal | 1 | 2010 | 770 | 0.050 |
Why?
|
| Macrophages, Peritoneal | 1 | 2004 | 74 | 0.050 |
Why?
|
| Cell Line | 2 | 2011 | 2036 | 0.050 |
Why?
|
| Point Mutation | 2 | 2018 | 168 | 0.050 |
Why?
|
| Humans | 10 | 2025 | 64914 | 0.050 |
Why?
|
| Immunity | 1 | 2004 | 108 | 0.050 |
Why?
|
| Transforming Growth Factor beta | 1 | 2004 | 182 | 0.050 |
Why?
|
| Lymphocyte Activation | 2 | 2004 | 752 | 0.050 |
Why?
|
| Lymphocytic choriomeningitis virus | 2 | 2019 | 88 | 0.050 |
Why?
|
| Retinoid X Receptor alpha | 1 | 2022 | 10 | 0.050 |
Why?
|
| Neoplasms, Experimental | 1 | 2003 | 77 | 0.050 |
Why?
|
| RNA-Binding Proteins | 1 | 2006 | 447 | 0.050 |
Why?
|
| Energy Metabolism | 1 | 2025 | 395 | 0.050 |
Why?
|
| Sex Factors | 1 | 2025 | 990 | 0.050 |
Why?
|
| In Vitro Techniques | 1 | 2003 | 493 | 0.050 |
Why?
|
| Rats | 2 | 2019 | 1995 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2002 | 104 | 0.050 |
Why?
|
| Enzyme Inhibitors | 1 | 2003 | 367 | 0.040 |
Why?
|
| MAP Kinase Signaling System | 2 | 2018 | 235 | 0.040 |
Why?
|
| Cell Line, Tumor | 2 | 2019 | 1566 | 0.040 |
Why?
|
| Neutropenia | 1 | 2020 | 68 | 0.040 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2002 | 344 | 0.040 |
Why?
|
| Insulin | 2 | 2017 | 696 | 0.040 |
Why?
|
| T-Lymphocytes | 1 | 2004 | 1007 | 0.040 |
Why?
|
| Glucose | 2 | 2015 | 476 | 0.040 |
Why?
|
| src-Family Kinases | 1 | 2019 | 64 | 0.040 |
Why?
|
| Disease Models, Animal | 2 | 2019 | 2284 | 0.040 |
Why?
|
| Arenaviridae Infections | 1 | 2019 | 15 | 0.040 |
Why?
|
| Skin Transplantation | 1 | 2019 | 154 | 0.030 |
Why?
|
| Conditioning, Classical | 1 | 2018 | 7 | 0.030 |
Why?
|
| Immunity, Innate | 1 | 2004 | 829 | 0.030 |
Why?
|
| Fatty Acids | 1 | 2019 | 197 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 2022 | 719 | 0.030 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2019 | 198 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2009 | 178 | 0.030 |
Why?
|
| Protein Interaction Mapping | 1 | 2017 | 69 | 0.030 |
Why?
|
| Anaerobiosis | 1 | 2017 | 13 | 0.030 |
Why?
|
| Proteomics | 1 | 2019 | 291 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2019 | 870 | 0.030 |
Why?
|
| Circadian Rhythm | 1 | 2020 | 390 | 0.030 |
Why?
|
| Glycolysis | 1 | 2017 | 58 | 0.030 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2011 | 312 | 0.030 |
Why?
|
| Nutritional Status | 1 | 2017 | 100 | 0.030 |
Why?
|
| Gene Regulatory Networks | 1 | 2017 | 160 | 0.030 |
Why?
|
| Agouti-Related Protein | 1 | 2016 | 6 | 0.030 |
Why?
|
| Hyperphagia | 1 | 2016 | 18 | 0.030 |
Why?
|
| Hippocampus | 1 | 2018 | 274 | 0.030 |
Why?
|
| Homeostasis | 1 | 2019 | 378 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 2017 | 414 | 0.030 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2015 | 36 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 2 | 2007 | 58 | 0.030 |
Why?
|
| Epigenesis, Genetic | 1 | 2017 | 405 | 0.030 |
Why?
|
| Cell Cycle | 2 | 2006 | 396 | 0.020 |
Why?
|
| Cell Division | 2 | 2004 | 448 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 9 | 2 | 2003 | 46 | 0.020 |
Why?
|
| Interleukin-6 | 2 | 2004 | 325 | 0.020 |
Why?
|
| Contact Inhibition | 1 | 2011 | 3 | 0.020 |
Why?
|
| Tumor Stem Cell Assay | 1 | 2011 | 17 | 0.020 |
Why?
|
| Gene Knockout Techniques | 1 | 2011 | 98 | 0.020 |
Why?
|
| Histone Deacetylases | 1 | 2011 | 66 | 0.020 |
Why?
|
| Ubiquitination | 1 | 2011 | 117 | 0.020 |
Why?
|
| Cadherins | 1 | 2011 | 90 | 0.020 |
Why?
|
| Recombinant Proteins | 2 | 2003 | 711 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2015 | 2053 | 0.020 |
Why?
|
| Organ Specificity | 1 | 2010 | 198 | 0.020 |
Why?
|
| Macrophages | 1 | 2015 | 1050 | 0.020 |
Why?
|
| Female | 2 | 2025 | 33873 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2009 | 197 | 0.020 |
Why?
|
| Pancreas | 1 | 2009 | 154 | 0.020 |
Why?
|
| Proteome | 1 | 2009 | 151 | 0.020 |
Why?
|
| Pregnancy | 1 | 2015 | 2366 | 0.020 |
Why?
|
| Feedback, Physiological | 1 | 2007 | 60 | 0.020 |
Why?
|
| Transcription Factors | 2 | 2006 | 1551 | 0.020 |
Why?
|
| Tumor Suppressor Protein p14ARF | 1 | 2006 | 13 | 0.020 |
Why?
|
| Base Sequence | 1 | 2009 | 1329 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2006 | 53 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2011 | 1035 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2007 | 215 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2009 | 1594 | 0.010 |
Why?
|
| mRNA Cleavage and Polyadenylation Factors | 1 | 2006 | 72 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2009 | 1985 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2006 | 112 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2006 | 610 | 0.010 |
Why?
|
| Young Adult | 1 | 2015 | 4783 | 0.010 |
Why?
|
| Dual-Specificity Phosphatases | 1 | 2004 | 9 | 0.010 |
Why?
|
| Receptor Cross-Talk | 1 | 2004 | 10 | 0.010 |
Why?
|
| Activin Receptors, Type I | 1 | 2004 | 15 | 0.010 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2004 | 30 | 0.010 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2004 | 61 | 0.010 |
Why?
|
| Bromodeoxyuridine | 1 | 2004 | 43 | 0.010 |
Why?
|
| Genes, Dominant | 1 | 2004 | 56 | 0.010 |
Why?
|
| Jurkat Cells | 1 | 2004 | 110 | 0.010 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2004 | 61 | 0.010 |
Why?
|
| Homozygote | 1 | 2004 | 122 | 0.010 |
Why?
|
| Adolescent | 1 | 2015 | 6283 | 0.010 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2004 | 59 | 0.010 |
Why?
|
| Cell Cycle Proteins | 1 | 2006 | 403 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 2006 | 331 | 0.010 |
Why?
|
| Neoplasm Invasiveness | 1 | 2004 | 285 | 0.010 |
Why?
|
| Activating Transcription Factor 2 | 1 | 2003 | 13 | 0.010 |
Why?
|
| Gene Deletion | 1 | 2004 | 311 | 0.010 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2003 | 46 | 0.010 |
Why?
|
| Wound Healing | 1 | 2004 | 193 | 0.010 |
Why?
|
| bcl-2 Homologous Antagonist-Killer Protein | 1 | 2002 | 11 | 0.010 |
Why?
|
| Cytochrome c Group | 1 | 2002 | 25 | 0.010 |
Why?
|
| MAP Kinase Kinase 7 | 1 | 2002 | 14 | 0.010 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2002 | 48 | 0.010 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 1 | 2002 | 24 | 0.010 |
Why?
|
| Cell Movement | 1 | 2004 | 478 | 0.010 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2004 | 348 | 0.010 |
Why?
|
| Receptors, Interleukin | 1 | 2002 | 38 | 0.010 |
Why?
|
| Inflammation Mediators | 1 | 2003 | 181 | 0.010 |
Why?
|
| Protein Binding | 1 | 2006 | 1642 | 0.010 |
Why?
|
| Caspase 3 | 1 | 2002 | 108 | 0.010 |
Why?
|
| Orthomyxoviridae Infections | 1 | 2002 | 60 | 0.010 |
Why?
|
| Interleukin-2 | 1 | 2002 | 166 | 0.010 |
Why?
|
| Cricetinae | 1 | 2002 | 369 | 0.010 |
Why?
|
| Lipopolysaccharides | 1 | 2004 | 621 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2004 | 687 | 0.010 |
Why?
|
| Ultraviolet Rays | 1 | 2002 | 146 | 0.010 |
Why?
|
| Caspases | 1 | 2002 | 176 | 0.010 |
Why?
|
| Lymph Nodes | 1 | 2002 | 231 | 0.010 |
Why?
|
| Interferon-gamma | 1 | 2003 | 574 | 0.010 |
Why?
|
| Spleen | 1 | 2002 | 474 | 0.010 |
Why?
|
| Influenza A virus | 1 | 2002 | 119 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2006 | 1578 | 0.010 |
Why?
|
| Gene Expression | 1 | 2003 | 856 | 0.010 |
Why?
|
| Mitochondria | 1 | 2002 | 402 | 0.010 |
Why?
|
| Adult | 1 | 2015 | 17279 | 0.010 |
Why?
|
| Middle Aged | 1 | 2015 | 18170 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2002 | 922 | 0.010 |
Why?
|
| Time Factors | 1 | 2002 | 3755 | 0.010 |
Why?
|